Paradigm

Dr. Shuhao Wen, co-founder and president of XtalPi

XtalPi and CK Life Sciences to Collaborate in Research and Development of AI-Based Tumor Vaccines, Opening a New Paradigm for Scientific Innovation | BioSpace

Leave a Comment / Artificial intelligence / By

AI-driven drug research and development (R&D) is breaking new ground, bringing faster and more effective treatment options to more patients worldwide SHENZHEN and HONG KONG, China, Nov. 24, 2022 /PRNewswire/ — XtalPi announced today the launch of a strategic collaboration with CK Life Sciences, member of the CK Hutchison Group. XtalPi and CK Life Sciences …

XtalPi and CK Life Sciences to Collaborate in Research and Development of AI-Based Tumor Vaccines, Opening a New Paradigm for Scientific Innovation | BioSpace Read More »

XtalPi and CK Life Sciences to Collaborate in Research and Development of AI-Based Tumor Vaccines, Opening a New Paradigm for Scientific Innovation

XtalPi and CK Life Sciences to Collaborate in Research and Development of AI-Based Tumor Vaccines, Opening a New Paradigm for Scientific Innovation

Leave a Comment / Artificial intelligence / By

Currently, there are only two therapeutic tumor vaccines, sipuleucel-T for melanoma and Bacillus Calmette-Guérin (BCG) for bladder cancer, as well as preventive tumor vaccines against infection with human papillomavirus and hepatitis B approved by the US Food and Drug Administration (FDA). Recently, several other tumor vaccines have entered clinical development and evidence of efficacy has …

XtalPi and CK Life Sciences to Collaborate in Research and Development of AI-Based Tumor Vaccines, Opening a New Paradigm for Scientific Innovation Read More »